Charles A Rowland Jr's Net Worth

$11.2 Million

Estimate Recalculated Jul 8, 2024 06:09PM EST

Who is Charles A Rowland Jr?

Charles A Rowland Jr has an estimated net worth of $11.2 Million. This is based on reported shares across multiple companies, which include DNIB UNWIND, INC., Nabriva Therapeutics Plc, Generation Bio Co., Blueprint Medicines Corp, Viking Therapeutics, Inc., Nabriva Therapeutics plc, Orchard Therapeutics plc, Vitae Pharmaceuticals, Inc, VIROPHARMA INC, IDENIX PHARMACEUTICALS INC, and ENDO PHARMACEUTICALS HOLDINGS INC.

SEC CIK

Charles A Rowland Jr's CIK is 0001383292

Past Insider Trading and Trends

2020 was Charles A Rowland Jr's most active year for acquiring shares with 13 total transactions. Charles A Rowland Jr's most active month to acquire stocks was the month of May. 2014 was Charles A Rowland Jr's most active year for disposing of shares, totalling 23 transactions. Charles A Rowland Jr's most active month to dispose stocks was the month of December. 2020 saw Charles A Rowland Jr paying a total of $877,652.77 for 271,098 shares, this is the most they've acquired in one year. In 2014 Charles A Rowland Jr cashed out on 573,765 shares for a total of $4,672,460.20, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DNIB UNWIND, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
15K
$0.44
$6,600.00
15K
Aug 26
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
May 28
Form 3
—
0
—
—
0
No matching records found

Nabriva Therapeutics Plc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 23
No matching records found

Generation Bio Co. (GBIO) Snapshot price: $1.875

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
+178.81%
342.96K
$1.39
$477,777.60
534.76K
Dec 1 - Dec 4
Form 4
—
0
—
—
0
Jun 8
Form 4
+8.95%
15.75K
$5.26
$82,845.00
191.8K
Sep 19
Form 4
+40.37%
50.63K
$5.46
$276,241.15
176.05K
Sep 15 - Sep 16
Form 4
+24.13%
24.38K
$5.22
$127,403.94
125.42K
Sep 13 - Sep 14
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 9
Form 4
+25.31%
20.41K
$24.50
$499,996.00
101.03K
Jan 11
Form 4
∞
80.63K
$19.00
—
80.63K
Jun 16
Form 4
—
0
—
—
0
Jun 11
Form 3
—
0
—
—
0
No matching records found

Blueprint Medicines Corp (BPMC) Snapshot price: $74.44

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+63.17%
2.25K
—
—
5.81K
Jun 2
Form 4
—
0
$68.68
-$1,072,245.61
3.56K
Dec 17
Form 4
—
0
$54.18
-$894,410.56
3.56K
Nov 2 - Nov 3
Form 4
+171.49%
2.25K
—
—
3.56K
Jun 24
Form 4
∞
1.31K
—
—
1.31K
Jun 19
Form 4
—
0
$52.31
-$1,012,664.08
0
Jun 20
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 23
Form 3
—
0
—
—
0
No matching records found

Viking Therapeutics, Inc. (VKTX) Snapshot price: $24.73

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
$13.04
-$956,800.00
30K
May 16
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 2
Form 4
∞
30K
$5.16
$154,800.00
30K
May 29
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jul 1
Form 3
—
0
—
—
0
No matching records found